PRIMARY STUDY

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities

Key Findings:  Pediatric patients with ASD received CBD (oil) for an average duration of 66 days. Specific reports indicate that self-injury and rage attacks improved in 67.6% and worsened in 8.8%. Hyperactivity symptoms improved in 68.4%. Sleep problems improved in 71.4% and worsened in 4.7%. Anxiety improved in 47.1% and worsened in 23.5%. Noted adverse effects included somnolence and change in appetite were mild.